Stay updated on Copanlisib and Nivolumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.

Latest updates to the Copanlisib and Nivolumab in Lymphoma Clinical Trial page
- Check3 days agoChange DetectedThe page’s deployment label was updated to include Revision: v3.6.2, while the previous label Revision: v3.6.0 was removed, indicating an updated build/version for the site.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now displays that recruitment has ended with 'No longer looking for participants.' New sections 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and 'Intervention/Treatment' were added, and the heading 'Intervention / Treatment' was removed along with the older 'Revision: v3.5.5' note.SummaryDifference0.4%

- Check24 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the study record. This reflects a maintenance or formatting update rather than any substantive changes to the study information.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page's revision label has been updated from v3.5.3 to v3.5.4, indicating a new page snapshot. This reflects a minor update to the page's version/history.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site build update rather than a change to the study details.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.5.2 has been added, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Copanlisib and Nivolumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.